Functioning of Kazakhstan's Initial Robotic Research Lab Unveiled
A New Era in Healthcare: Abbott's Automated Laboratory Line Revolutionises Diagnostics in Kazakhstan
A significant advancement in healthcare technology has been made in Kazakhstan with the introduction of Abbott's GLP Systems automated laboratory line. This cutting-edge technology, showcased at 52 Kudaikeryuly Street in Astana, is set to transform the diagnostic landscape in the country.
Tatyana Tyaglya, head of the capital's Invivo laboratory, led a tour of the new facility, revealing a system that optimises laboratory resources, speeds up the issuance of results, and reduces errors due to manual labour. The system, consisting of several modules, includes one for loading test tubes in bulk.
Roman Chernov, the general director of Invivo laboratory network, chose Abbott equipment because of its proven track record and user-friendly, space-saving features. He stated that they will fully automate the laboratory line in Almaty by the start of next year, followed by Shymkent and Aktau.
The system operates within the guaranteed volume of free medical care and the mandatory social medical insurance system (GOBMP and OSMS). Invivo invested over one million dollars in equipment for the automated laboratory line, excluding analyzers. Aiganym Askarova, product manager of Invivo lab, highlighted the importance of seminars next year to train doctors and nurses to work with and interpret test results.
Invivo uses high-quality reagents, conducts daily internal quality control and inter-laboratory comparative tests, and participates in external quality assessment programs for all test types. They also use Abbott equipment, which only allows for the use of Abbott reagents, eliminating the possibility of using substandard products.
The GLP Systems automated laboratory line sorts and raises the test tubes by conveyor, places them on a transport machine, and distributes them to the analyzers according to the given task. This integration of advanced robotics and software streamlines testing workflows, reducing human error, increasing consistency in test results, and enabling laboratories to handle a higher volume of samples with improved turnaround times.
The benefits of this automation are crucial in Kazakhstan where access to cutting-edge healthcare technology can significantly elevate the quality and reliability of medical diagnostics. Aiganym Askarova emphasised the importance of the new lab for enabling lab technicians to interact simultaneously with practicing doctors and patients through the "doctor-doctor" and "doctor-patient" systems during tests.
Stanko Klipa, director of Abbott's business distribution, commented that the opening of this laboratory is a significant step for Abbott, Invivo, and healthcare in Kazakhstan. Stefano Paoloni, Abbott's managing director of distribution, was impressed by the world-class laboratory he saw and thanked Invivo for the opportunity to work in Kazakhstan.
Roman Chernov expressed hope that after implementing automated technology, patients will receive more accurate and reliable test results in a shorter time, enabling them to live longer and better lives. Abbott operates in 116 countries worldwide, and this marks a significant expansion of its presence in Kazakhstan, aligning with broader efforts to strengthen healthcare capacities through technology adoption in the region.
The GLP Systems automated laboratory line, introduced by Abbott, is revolutionizing medical-conditions diagnostics in Kazakhstan by optimizing resources, speeding up result issuance, and reducing errors. This technology, a significant advancement in health-and-wellness, operates using advanced robotics and software, integrating technology into healthcare.
